Human Medicines European Public Assessment Report (EPAR): Retacrit, Epoetin Zeta, Anemia,Blood Transfusion, Autologous,Kidney Failure, Chronic,Cancer, Date of Authorisation: 18/12/2007, Revision: 23, Status: Authorised

Case Medical Research
doi 10.31525/cmr-12043f3
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): Mircera, Methoxy Polyethylene Glycol-Epoetin Beta, Anemia,Kidney Failure, Chronic, Date of Authorisation: 20/07/2007, Revision: 24, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Intelence, Etravirine, HIV Infections, Date of Authorisation: 28/08/2008, Revision: 23, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Levetiracetam Sun, Levetiracetam, Epilepsy, Date of Authorisation: 14/12/2011, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Entecavir Mylan, Entecavir, Hepatitis B, Date of Authorisation: 18/09/2017, Revision: 1, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Mixtard, Insulin Human (rDNA), Diabetes Mellitus, Date of Authorisation: 07/10/2002, Revision: 18, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Instanyl, Fentanyl, Pain,Cancer, Date of Authorisation: 20/07/2009, Revision: 21, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Betmiga, Mirabegron, Urinary Bladder, Overactive, Date of Authorisation: 20/12/2012, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Olazax, Olanzapine, Schizophrenia,Bipolar Disorder, Date of Authorisation: 11/12/2009, Revision: 10, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Rebetol, Ribavirin, Hepatitis C, Chronic, Date of Authorisation: 06/05/1999, Revision: 32, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy